Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma

The identification of prognostic markers for hepatocellular carcinoma (HCC) is needed for clinical practice. Tripartite motif-containing 35 (TRIM35) is a tumor suppressor of HCC. TRIM35 inhibits phosphorylation of pyruvate kinase isoform M2 (PKM2), which is involved in aerobic glycolysis of cancer c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chen, Zhiao, Lu, Xinyuan, Wang, Zhichao, Jin, Guangzhi, Wang, Qifeng, Chen, Di, Chen, Taoyang, Li, Jinjun, Fan, Jia, Cong, Wenming, Gao, Qiang, He, Xianghuo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385869/
https://ncbi.nlm.nih.gov/pubmed/25576919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados